Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16


The Saudi Initiative for Asthma - 2016 update: Guidelines for the diagnosis and management of asthma in adults and children.

Al-Moamary MS, Alhaider SA, Idrees MM, Al Ghobain MO, Zeitouni MO, Al-Harbi AS, Yousef AA, Al-Matar H, Alorainy HS, Al-Hajjaj MS.

Ann Thorac Med. 2016 Jan-Mar;11(1):3-42. doi: 10.4103/1817-1737.173196.


Are inhaled long-acting Beta-agonists (laba) really harmful in adult asthmatics?

Khajotia R, Tnew C.

Malays Fam Physician. 2008 Aug 31;3(2):98-100. eCollection 2008. No abstract available.


β2 adrenergic agonist attenuates house dust mite-induced allergic airway inflammation through dendritic cells.

Kato G, Takahashi K, Tashiro H, Kurata K, Shirai H, Kimura S, Hayashi S.

BMC Immunol. 2014 Oct 30;15:39. doi: 10.1186/s12865-014-0039-y.


Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone.

Bateman ED, O'Byrne PM, Busse WW, Lötvall J, Bleecker ER, Andersen L, Jacques L, Frith L, Lim J, Woodcock A.

Thorax. 2014 Apr;69(4):312-9. doi: 10.1136/thoraxjnl-2013-203600. Epub 2013 Nov 19.


Section 1. EPR-3 versus GINA 2008 Guidelines - Asthma Control and Step 3 Care: Highlights of the Asthma Summit 2009: Beyond the Guidelines.

Bousquet J, Busse WW.

World Allergy Organ J. 2010 Feb 15;3(2):16-22. doi: 10.1097/WOX.0b013e3181cb90c3.


Efficacy and safety of fluticasone furoate/vilanterol compared with fluticasone propionate/salmeterol combination in adult and adolescent patients with persistent asthma: a randomized trial.

Woodcock A, Bleecker ER, Lötvall J, O'Byrne PM, Bateman ED, Medley H, Ellsworth A, Jacques L, Busse WW.

Chest. 2013 Oct;144(4):1222-1229. doi: 10.1378/chest.13-0178.


The Saudi initiative for asthma - 2012 update: Guidelines for the diagnosis and management of asthma in adults and children.

Al-Moamary MS, Alhaider SA, Al-Hajjaj MS, Al-Ghobain MO, Idrees MM, Zeitouni MO, Al-Harbi AS, Al Dabbagh MM, Al-Matar H, Alorainy HS.

Ann Thorac Med. 2012 Oct;7(4):175-204. doi: 10.4103/1817-1737.102166.


The role of tiotropium in the management of asthma.

Park HW.

Asia Pac Allergy. 2012 Apr;2(2):109-14. doi: 10.5415/apallergy.2012.2.2.109. Epub 2012 Apr 30.


Drug prescription pattern for asthma among nigerian doctors in general practice: A cross-sectional survey.

Fawibe AE, Onyedum CC, Sogaolu OM, Ajayi AO, Fasae AJ.

Ann Thorac Med. 2012 Apr;7(2):78-83. doi: 10.4103/1817-1737.94524.


Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults.

Lougheed MD, Lemiere C, Ducharme FM, Licskai C, Dell SD, Rowe BH, Fitzgerald M, Leigh R, Watson W, Boulet LP; Canadian Thoracic Society Asthma Clinical Assembly.

Can Respir J. 2012 Mar-Apr;19(2):127-64. Erratum in: Can Respir J. 2013 May-Jun;20(3):185.


The relationship between combination inhaled corticosteroid and long-acting β-agonist use and severe asthma exacerbations in a diverse population.

Wells KE, Peterson EL, Ahmedani BK, Severson RK, Gleason-Comstock J, Williams LK.

J Allergy Clin Immunol. 2012 May;129(5):1274-1279.e2. doi: 10.1016/j.jaci.2011.12.974. Epub 2012 Jan 26.


Systemic bioavailability of hydrofluoroalkane (HFA) formulations of fluticasone/salmeterol in healthy volunteers via pMDI alone and spacer.

Clearie KL, Williamson PA, Vaidyanathan S, Du Bois J, Nell H, Lipworth BJ.

Br J Clin Pharmacol. 2010 Jun;69(6):637-44. doi: 10.1111/j.1365-2125.2010.03655.x.


Long-term maintenance of pediatric asthma: focus on budesonide/formoterol inhalation aerosol.

Huynh PN, Scott LG, Kwong KY.

Ther Clin Risk Manag. 2010 Mar 3;6:65-75.


The Saudi Initiative for Asthma.

Al-Moamary MS, Al-Hajjaj MS, Idrees MM, Zeitouni MO, Alanezi MO, Al-Jahdali HH, Al Dabbagh M.

Ann Thorac Med. 2009 Oct;4(4):216-33. doi: 10.4103/1817-1737.56001.


Asthma exacerbations . 4: Prevention.

FitzGerald JM, Gibson PG.

Thorax. 2006 Nov;61(11):992-9. Review.


Clinical importance of the Step 3 choice in asthma.

Barnes ML, Lipworth BJ.

Thorax. 2006 Feb;61(2):180-1; author reply 181. No abstract available.

Supplemental Content

Support Center